Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2009, Article ID 715057, 9 pages
http://dx.doi.org/10.1155/2009/715057
Research Article

Effect of Food Restriction on Adipose Tissue in Spontaneously Diabetic Torii Fatty Rats

1Japan Tobacco Inc., Central Pharmaceutical Research Institute, 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan
2Japan Tobacco Inc., Toxicology Research Laboratories, Central Pharmaceutical Research Institute, 23 Naganuki, Hadano, Kanagawa 257-0024, Japan

Received 24 February 2009; Accepted 8 June 2009

Academic Editor: Ryuichi Kikkawa

Copyright © 2009 Hisayo Morinaga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Masuyama, Y. Katsuda, and M. Shinohara, “A novel model of obesity-related diabetes: introgression of the Leprfa allele of the Zucker fatty rat into nonobese Spontaneously Diabetic Torii (SDT) rats,” Experimental Animals, vol. 54, no. 1, pp. 13–20, 2005. View at Publisher · View at Google Scholar
  2. M. Shinohara, T. Masuyama, T. Shoda et al., “A new spontaneously diabetic non-obese torii rat strain with severe ocular complications,” Experimental Diabetes Research, vol. 1, no. 2, pp. 89–100, 2000. View at Google Scholar
  3. T. Masuyama, M. Fuse, N. Yokoi et al., “Genetic analysis for diabetes in a new rat model of nonobese type 2 diabetes, Spontaneously Diabetic Torii rat,” Biochemical and Biophysical Research Communications, vol. 304, no. 1, pp. 196–206, 2003. View at Publisher · View at Google Scholar
  4. T. Sasase, T. Ohta, N. Ogawa et al., “Preventive effects of glycaemic control on ocular complications of Spontaneously Diabetic Torii rat,” Diabetes, Obesity and Metabolism, vol. 8, no. 5, pp. 501–507, 2006. View at Publisher · View at Google Scholar
  5. K. Matsui, T. Ohta, T. Oda et al., “Diabetes-associated complications in Spontaneously Diabetic Torii fatty rats,” Experimental Animals, vol. 57, no. 2, pp. 111–121, 2008. View at Publisher · View at Google Scholar
  6. A. N. Peiris, M. F. Struve, R. A. Mueller, M. B. Lee, and A. H. Kissebah, “Glucose metabolism in obesity: influence of body fat distribution,” Journal of Clinical Endocrinology and Metabolism, vol. 67, no. 4, pp. 760–767, 1988. View at Google Scholar
  7. P. Bjorntorp, “Metabolic implications of body fat distribution,” Diabetes Care, vol. 14, no. 12, pp. 1132–1143, 1991. View at Google Scholar
  8. A. H. Kissebah, “Insulin resistance in visceral obesity,” International Journal of Obesity, vol. 15, supplement 2, pp. 109–115, 1991. View at Google Scholar
  9. D. G. Carey, A. B. Jenkins, L. V. Campbell, J. Freund, and D. J. Chisholm, “Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM,” Diabetes, vol. 45, no. 5, pp. 633–638, 1996. View at Google Scholar
  10. N. Barzilai, S. Banerjee, M. Hawkins, W. Chen, and L. Rossetti, “Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat,” The Journal of Clinical Investigation, vol. 101, pp. 1353–1361, 1998. View at Google Scholar
  11. I. Gabriely, X. H. Ma, X. M. Yang, L. Rossetti, and N. Barzilai, “Leptin resistance during aging is independent of fat mass,” Diabetes, vol. 51, no. 4, pp. 1016–1021, 2002. View at Google Scholar
  12. T. Masuyama, K. Komeda, A. Hara et al., “Chronological characterization of diabetes development in male Spontaneously Diabetic Torii rats,” Biochemical and Biophysical Research Communications, vol. 314, no. 3, pp. 870–877, 2004. View at Publisher · View at Google Scholar
  13. T. Ohta, K. Matsui, K. Miyajima et al., “Effect of insulin therapy or renal changes in spontaneously diabetic Torii rats,” Experimental Animals, vol. 56, no. 5, pp. 355–362, 2007. View at Publisher · View at Google Scholar
  14. M. Colombo, M. Kruhoeffer, S. Gregersen et al., “Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis,” Metabolism, vol. 55, no. 1, pp. 43–52, 2006. View at Publisher · View at Google Scholar
  15. M. Kimura, T. Shinozaki, N. Tateishi et al., “Adiponectin is regulated differently by chronic exercise than by weight-matched food restriction in hyperphagic and obese OLETF rats,” Life Sciences, vol. 79, no. 22, pp. 2105–2111, 2006. View at Publisher · View at Google Scholar
  16. F. Escrivá, M. L. Gavete, Y. Fermín et al., “Effect of age and moderate food restriction on insulin sensitivity in Wistar rats: role of adiposity,” Journal of Endocrinology, vol. 194, no. 1, pp. 131–141, 2007. View at Publisher · View at Google Scholar
  17. M. C. Sugden, R. M. Grimshaw, H. Lall, and M. J. Holness, “Regional variations in metabolic responses of white adipose tissue to food restriction,” American Journal of Physiology, vol. 267, no. 5174, pp. E892–E899, 1994. View at Google Scholar
  18. G. R. Hynes, J. Heshka, K. Chadee, and P. J. Jones, “Effects of dietary fat type and energy restriction on adipose tissue fatty acid composition and leptin production in rats,” Journal of Lipid Research, vol. 44, no. 5, pp. 893–901, 2003. View at Publisher · View at Google Scholar
  19. M. J. Azain, D. B. Hausman, T. R. Kasser, and R. J. Martin, “Effect of somatotropin and feed restriction on body composition and adipose metabolism in obese Zucker rats,” American Journal of Physiology, vol. 269, no. 1, pp. E137–E144, 1995. View at Google Scholar
  20. I. E. Kelly, T. S. Han, K. Walsh, and M. E. J. Lean, “Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes,” Diabetes Care, vol. 22, no. 2, pp. 288–293, 1999. View at Publisher · View at Google Scholar
  21. Y. Miyazaki, A. Mahankali, M. Matsuda et al., “Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 6, pp. 2784–2791, 2002. View at Publisher · View at Google Scholar
  22. D. E. Kelley, F. L. Thaete, F. Troost, T. Huwe, and B. H. Goodpaster, “Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance,” American Journal of Physiology, vol. 278, no. 5, pp. E941–E948, 2000. View at Google Scholar
  23. R. Ross, J. Aru, J. Freeman, R. Hudson, and I. Janssen, “Abdominal adiposity and insulin resistance in obese men,” American Journal of Physiology, vol. 282, no. 3, pp. E657–E663, 2002. View at Google Scholar
  24. J.-P. Despres, A. Nadeau, A. Tremblay et al., “Role of deep abdominal fat in the association between regional adipose tissue distributioin and glucose tolerance in obese women,” Diabetes, vol. 38, no. 3, pp. 304–309, 1989. View at Google Scholar
  25. S. R. Colberg, J.-A. Simoneau, F. L. Thaete, and D. E. Kelley, “Skeletal muscle utilization of free fatty acids in women with visceral obesity,” Journal of Clinical Investigation, vol. 95, no. 4, pp. 1846–1853, 1995. View at Google Scholar
  26. P. Bjorntorp, ““Portal” adipose tissue as a generator of risk factors for cardiovascular disease and diabetes,” in Arteriosclerosis, vol. 10, no. 4, pp. 493–496, 1990.
  27. J.-P. Despres, “Abdominal obesity as important component of insulin-resistance syndrome,” Nutrition, vol. 9, no. 5, pp. 452–459, 1993. View at Google Scholar
  28. O. Pedersen, C. R. Kahn, J. S. Flier, and B. B. Kahn, “High fat feeding causes insulin resistance and a marked decrease in the expression of glucose transporters (glut 4) in fat cells of rats,” Endocrinology, vol. 129, no. 2, pp. 771–777, 1991. View at Google Scholar
  29. M. C. Cha and P. J. H. Jones, “Dietary fat type and energy restriction interactively influence plasma leptin concentration in rats,” Journal of Lipid Research, vol. 39, no. 8, pp. 1655–1660, 1998. View at Google Scholar
  30. A. Okuno, H. Tamemoto, K. Tobe et al., “Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats,” Journal of Clinical Investigation, vol. 101, no. 6, pp. 1354–1361, 1998. View at Google Scholar
  31. T. Shibata, K. Matsui, F. Yonemori, and K. Wakitani, “JTT-501, a novel oral antidiabetic agent, improves insulin resistance in genetic and non-genetic insulin-resistant models,” British Journal of Pharmacology, vol. 125, no. 8, pp. 1744–1750, 1998. View at Publisher · View at Google Scholar
  32. P. J. Scarpace, M. Nicolson, and M. Matheny, “UCP2, UCP3 and leptin gene expression: modulation by food restriction and leptin,” Journal of Endocrinology, vol. 159, no. 2, pp. 349–357, 1998. View at Google Scholar
  33. C. Fernández-Galaz, T. Fernández-Agulló, C. Pérez et al., “Long-term food restriction prevents ageing-associated central leptin resistance in wistar rats,” Diabetologia, vol. 45, no. 7, pp. 997–1003, 2002. View at Publisher · View at Google Scholar
  34. H. Zhou, X. Song, M. Briggs et al., “Adiponectin represses gluconeogenesis independent of insulin in hepatocytes,” Biochemical and Biophysical Research Communications, vol. 338, no. 2, pp. 793–799, 2005. View at Publisher · View at Google Scholar
  35. G. Yang, L. Li, Y. Tang, and G. Boden, “Short-term pioglitazone treatment prevents free fatty acid-induced hepatic insulin resistance in normal rats: possible role of the resistin and adiponectin,” Biochemical and Biophysical Research Communications, vol. 339, no. 4, pp. 1190–1196, 2006. View at Publisher · View at Google Scholar
  36. W. I. Sivitz, S. L. DeSautel, E. C. Lee, and J. E. Pessin, “Time-dependent regulation of rat adipose tissue glucose transporter (GLUT4) mRNA and protein by insulin in streptozocin-diabetic and normal rats,” Metabolism, vol. 41, no. 11, pp. 1267–1272, 1992. View at Publisher · View at Google Scholar
  37. D. J. Becker, L. N. Ongemba, V. Brichard, J.-C. Henquin, and S. M. Brichard, “Diet- and diabetes-induced changes of ob gene expression in rat adipose tissue,” FEBS Letters, vol. 371, no. 3, pp. 324–328, 1995. View at Publisher · View at Google Scholar
  38. H. S. Ahuja, S. Liu, D. L. Crombie et al., “Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents,” Molecular Pharmacology, vol. 59, no. 4, pp. 765–773, 2001. View at Google Scholar
  39. M. Furuta, Y. Yano, E. C. Gabazza et al., “Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 56, no. 3, pp. 159–171, 2002. View at Publisher · View at Google Scholar